EGFR Exon 20 Insertion As A Therapeutic Target in Non-small Cell Lung Cancer - Episode 9

OncView™ Podcast: EGFR Exon 20 Insertion as a Therapeutic Target in NSCLC

In an OncView™ program, Zofia Piotrowska, MD, touched on testing, treatment approaches, and therapeutic options for EGFR exon 20 insertion mutations in non–small cell lung cancer.

As part of its OncView video series, CancerNetwork® spoke with Zofia Piotrowska, MD, an assistant professor of medicine at Harvard Medical School and a medical oncologist at Massachusetts General Hospital, about recent data and review updates in the treatment landscape for patients with metastatic non–small cell lung cancer harboring EGFR exon 20 insertion mutations.

In the video series, Piotrowska discussed the following:

To watch more videos in the CancerNetwork® OncViewseries, visit

Don’t forget to subscribe to the “Oncology Peer Review On-The-Go” podcast on Apple Podcasts, Spotify, or anywhere podcasts are available.